IIT Delhi Start-ups Launch Affordable Antiviral Protection Kit

IIT Delhi Start-ups Launch Affordable Antiviral Protection Kit

  • News
  • 1K

Indian Institute of Technology, Delhi incubated startups E-TEX and Clensta have teamed up and launched a complete antiviral protection kit for the masses at an affordable price on the occasion of Mahatma Gandhi’s birth anniversary. This antiviral protection kit has been launched with an ambition to provide protective cover to people amid the COVID-19 pandemic.

The antiviral kit, unveiled by Prof V. Ramgopal Rao, Director, IIT Delhi, consists of a novel Clensta protection lotion and hand sanitizer; E-TEX Kawach Antiviral T-Shirt, and Kawach Mask. The products are backed up by experts from the chemical and textile departments of IIT Delhi.

E-TEX Kawach Antiviral Garment with its antiviral fabric has been designed using advanced technology; this inhibits from hosting microbes, reduces the likelihood and speed of contaminations, transmissions by destroying micro-organisms on contact. The antimicrobial property of the garment remains effective even after 30 washes in mild condition. The finishing is done on cellulosic fibers, which is safe for human contact and on the environment.

Speaking after launching the kit, Prof Rao said, “It is indeed a proud moment for IIT Delhi to see such Indigenous technologies impacting and creating job opportunities amidst this pandemic and making India Atmanirbhar.”

Prof Bipin Kumar, Department of Textile and Fibre Engineering, IIT Delhi & Mentor, E-TEX said, “The COVID-19 pandemic is pushing for an all-time-high demand of multifunctional anti-viral and microbial apparels. Developing cost-effective bio-clothing with antiviral and antimicrobial functionalities through local resources and resilient manufacturing can deactivate the viral threats; can efficiently stop/slow the spread of the virus. Further, this will boost the local economy for the textile and garment sectors.”

Clensta Protection Lotion, launched under brand name COVID-19 Protection Lotion, offers 99.9% virus protection with antiviral and antiseptic properties for up to 24 hours. The product is a breakthrough advancement in the formulation of engineering chemistry with first of its kind PAP Technology (Prolonged Antiviral Technology) to prevent bacterial, viral, and fungal infections without harming the environment and human health. Advanced Hand Sanitizer is formulated with increased alcohol retention time to be effective prevention against multiple viruses.

The product can be used over any exposed part of the body including the face and hands. The application of the product keeps users safe from viruses by disrupting it for almost 24 hours and reduces the extended use of alcohol-based sanitizers and washing hands multiple times a day. The antiviral efficacy of the Clensta lotion was conducted at different intervals of times and found to be 99.95% effective in virus protection as per American Society for Testing & Materials, says an IIT Delhi statement. (ISW)

If you liked this article, then please subscribe to our YouTube Channel for the latest Science & Tech news. You can also find us on Twitter & Facebook

Rate

0 out of 5 stars(0 ratings)
Ethical Framework and Standards Needed for AI Systems

Ethical Framework and Standards Needed for AI Systems

If India wants to catch up with China and other countries in the emerging field of Artificial Intelligence it will have to make huge investments in developing all enabling technologies and necessary eco-system, and also develop a framework for ethics and standards in AI

  • News
  • 1.8K
Read more

Repurposed Asthma Drug Shows Blood Sugar Improvement among Some Diabetics

After 12 weeks of taking an anti-asthma drug, a subset of patients with type 2 diabetes showed a clinically significant reduction in blood glucose during a randomized, double-blind, placebo-controlled clinical trial, report University of California San Diego School of Medicine and University of Michigan researchers.

  • News
  • 1.1K
Read more
Japan and Singapore Grant CRISPR Patents to Merck

Japan and Singapore Grant CRISPR Patents to Merck

Merck, a leading science and technology company, today announced that the Japan Patent Office and the Intellectual Property Office of Singapore have each allowed the company's patent application for the use of paired CRISPR nickases, bringing Merck's number of patents to 22 worldwide

  • News
  • 1.2K
Read more

Internet is huge! Help us find great content

Newsletter

Never miss a thing! Sign up for our newsletter to stay updated.

About

Research Stash is a curated collection of tools and News for S.T.E.M researchers

Have any questions or want to partner with us? Reach us at hello@researchstash.com

Navigation

Submit